PART 2: RE-DUAL PCI – Diabetes sub-group analysis
- Understand the latest data in relation to the NOACs and its implication on selected subgroups of populations.
- Interpret the new data on the treatment of patients with atrial fibrillation and when to apply dual vs triple therapy treatment.
- Understand the implementation of the emerging data and which patient groups should be treated differently.
This video series was funded by an unrestricted educational service from Boehringer Ingelheim.